All cancer types
Open
Phase 1
This study is looking at tolinapant (ASTX660) with pembrolizumab for people with cancer that has spread and whose treatment has stopped working.
It is for people with a . This is any cancer apart from a blood cancer such as leukaemia.
You pronounce tolinapant as tuh-lin-a-pant.
Cancer Research UK supports this study.
Recruitment start: 15 March 2022
Recruitment end: 31 January 2026
Please note: In order to join a trial you will need to discuss it with your doctor, unless otherwise specified.
Dr Juanita Lopez
Cancer Research UK
Institute of Cancer Research (ICR)
This is Cancer Research UK trial number CRUK/21/016.
Last reviewed: 05 Mar 2025
CRUK internal database number: 19938
About Cancer generously supported by Dangoor Education since 2010. Learn more about Dangoor Education
What to ask your doctor about clinical trials.
Meet and chat to other cancer people affected by cancer.
Questions about cancer? Call freephone 0808 800 40 40 from 9 to 5 - Monday to Friday. Alternatively, you can email us.
